의료 및 헬스케어용 전자기기 시장 예측(-2034년) : 디바이스 유형별, 제품 유형, 기술, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Medical & Healthcare Electronics Market is accounted for $198.1 billion in 2026 and is expected to reach $345.5 billion by 2034 growing at a CAGR of 7.2% during the forecast period. Medical & Healthcare Electronics focuses on devices and technologies that aid in patient monitoring, diagnosis, and treatment, improving overall healthcare delivery. This domain covers wearables, imaging systems, diagnostic instruments, telehealth devices, and electronic health record platforms. Market growth is fueled by technological innovation, increasing chronic disease rates, and the rising use of connected healthcare solutions. Incorporating AI, IoT, and analytics allows for continuous monitoring, predictive care, and tailored treatment plans. Additionally, supportive government programs and heightened patient awareness are driving global adoption and expansion of medical electronic solutions.

According to the World Health Organization (WHO), global healthcare spending reached USD 9.8 trillion in 2021, with a significant portion directed toward medical devices and electronic health technologies, reflecting the increasing reliance on electronics in diagnostics, monitoring, and treatment.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

The surge in chronic diseases like diabetes, heart conditions, and lung disorders is boosting the adoption of healthcare electronics. Devices such as wearables, monitoring systems, and diagnostic tools enable effective management, timely intervention, and early detection. Medical facilities and home-care setups increasingly depend on these technologies for better patient care and outcomes. As demand for efficient disease management grows, healthcare providers are investing more in advanced medical electronics, positioning the prevalence of chronic diseases as a major driver accelerating growth in the medical and healthcare electronics market.

Restraint:

High cost of advanced medical devices

Expensive medical electronics, such as advanced diagnostic tools, wearable health monitors, and AI-enabled devices, act as a barrier to adoption, particularly in emerging markets. Budget constraints in small hospitals and clinics prevent investment in high-cost technologies. Additionally, ongoing maintenance, calibration, and software updates raise the total expenditure. Even though these devices enhance patient care and operational efficiency, their high price limits widespread implementation. Consequently, the cost factor remains a key restraint for the medical and healthcare electronics market, slowing growth and restricting accessibility for healthcare providers in resource-limited regions.

Opportunity:

Expansion of telehealth and remote patient monitoring

The increasing adoption of telemedicine and remote monitoring offers substantial growth potential for healthcare electronics. Wearables, mobile apps, and connected diagnostic devices facilitate continuous health tracking at home, lowering hospital dependency and improving outcomes. Coupled with AI analytics and electronic health records, these technologies enable personalized care. Rising demand from elderly and chronic patients drives new product innovation and market expansion. This shift toward home-based, tech-enabled healthcare services creates opportunities for manufacturers and service providers to introduce advanced monitoring solutions, expand market reach, and cater to patient-centered care trends in both developed and emerging regions.

Threat:

Intense competition and market saturation

The medical electronics sector is highly competitive, with multinational corporations, startups, and regional manufacturers vying for market share. This rivalry can result in price reductions and thinner margins. Continuous innovation requires constant product upgrades, raising R&D expenditures. Saturation in mature markets limits growth, making it difficult to differentiate products. Such pressures can hinder revenue expansion and overall profitability. To stay competitive, companies must focus on innovation, operational efficiency, and strategic alliances. Consequently, intense competition and market saturation remain critical threats, challenging firms to sustain growth and maintain a strong position in the medical and healthcare electronics market.

Covid-19 Impact:

The COVID-19 crisis profoundly impacted the medical electronics sector, driving faster adoption of telehealth and remote monitoring technologies. Devices such as wearables, ventilators, and connected diagnostic tools became essential for managing patient care while reducing hospital congestion. AI and IoT-enabled systems allowed real-time monitoring, predictive analytics, and safer treatment. Although supply chain interruptions temporarily hindered production, government interventions and emergency funding supported rapid device deployment. The pandemic emphasized the critical role of advanced medical electronics, fostering innovation, accelerating market growth, and promoting a global transition toward connected, technology-driven, and remote healthcare services.

The diagnostic equipment segment is expected to be the largest during the forecast period

The diagnostic equipment segment is expected to account for the largest market share during the forecast period due to its essential role in early detection, precise diagnosis, and preventive care. Tools such as imaging systems, laboratory analyzers, and point-of-care testing devices are extensively used in hospitals, clinics, and labs. The increasing incidence of chronic and infectious diseases, alongside innovations in AI, IoT, and imaging technologies, drives demand. Healthcare providers emphasize diagnostics to enable prompt intervention and improved patient outcomes, positioning this segment as a primary growth driver and a core area of focus within the medical and healthcare electronics industry.

The AI & machine learning applications segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI & machine learning applications segment is predicted to witness the highest growth rate, fueled by their ability to revolutionize diagnostics, monitoring, and individualized care. These technologies process extensive health data from wearables, imaging systems, and electronic records to identify early disease signs, forecast patient outcomes, and enhance treatment strategies. Rising demand for intelligent, analytics-driven healthcare solutions, along with expanding use of AI-enabled devices and platforms in hospitals and remote care, positions this segment as the highest-growing. It is a key driver of innovation, operational efficiency, and advanced patient care in the medical and healthcare electronics industry.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, fueled by advanced healthcare systems, widespread use of digital solutions, and supportive government initiatives. Major medical device companies, research centers, and tech-focused hospitals facilitate rapid adoption of AI, IoT, and connected healthcare tools. Increasing chronic disease prevalence, aging demographics, and higher health awareness boost demand for diagnostic, monitoring, and therapeutic devices. Substantial R&D investments, favorable reimbursement schemes, and strong regulatory support reinforce the region's dominance, positioning North America as the leading contributor to the global growth of the medical and healthcare electronics industry.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by higher healthcare expenditure, growing health awareness, and quick adoption of modern medical technologies. Expansion of hospitals, healthcare networks, and supportive government programs boost demand for diagnostic, monitoring, and therapeutic devices. A large population, rising chronic disease incidence, and growing use of telemedicine, wearable devices, and AI-powered solutions contribute to rapid market expansion. Sustained investments in healthcare infrastructure and technological innovation make Asia Pacific the highest-growth rate region, offering significant opportunities and emerging as a leading growth hub in the global medical and healthcare electronics sector.

Key players in the market

Some of the key players in Medical & Healthcare Electronics Market include Analog Devices, Inc., TE Connectivity, Texas Instruments Incorporated, STMicroelectronics, NXP Semiconductors, Infineon Technologies AG, GE HealthCare, Microchip Technology Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Becton, Dickinson and Company, Dragerwerk AG & Co. KGaA and Stryker.

Key Developments:

In October 2025, Infineon Technologies AG has signed power purchase agreements (PPA) with PNE AG and Statkraft to procure wind and solar electricity for its German facilities. Under a 10-year deal with German renewables developer and wind power producer PNE AG, Infineon will buy electricity from the Schlenzer and Kittlitz III wind farms in Brandenburg, Germany, which have a combined capacity of 24 MW, for its sites in Dresden, Regensburg, Warstein and Neubiberg near Munich.

In February 2025, NXP Semiconductors has acquired AI chip startup Kinara in a $307 million all-cash agreement. NXP said the acquisition would enable it to "enhance and strengthen" its ability to provide scalable AI platforms by combining Kinara's NPUs and AI software with NXP's solutions portfolio. Kinara develops programmable neural processing units (NPUs) for Edge AI applications, including multi-modal generative AI models.

In December 2024, Texas Instruments (TI) and the U.S. Department of Commerce announced an award agreement of up to $1.6 billion in direct funding through the U.S. CHIPS and Science Act, following the preliminary memorandum of terms announced in August 2024. The funding will help support three of TI's new 300mm wafer fabs currently under construction in Texas and Utah. Support from the CHIPS Act, including the 25% investment tax credit, will help TI provide a geopolitically dependable supply of essential analog and embedded processing semiconductors.

Device Types Covered:

• Diagnostic Equipment
• Therapeutic Equipment
• Monitoring Devices
• Surgical Instruments

Product Models Covered:

• Portable Devices
• Stationary Devices
• Integrated Systems

Technologies Covered:

• Wearable Technology
• Telemedicine Platforms
• Health Information Technology (HIT)
• Telemonitoring Systems
• IoT & Connected Devices
• AI & Machine Learning Applications

Applications Covered:

• Functional Applications
• Clinical Domains

End Users Covered:

• Hospitals & Clinics
• Ambulatory Surgical Centers (ASCs)
• Home Healthcare
• Diagnostic Laboratories
• Research Institutes

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Medical & Healthcare Electronics Market, By Device Type

• 5.1 Diagnostic Equipment
• 5.2 Therapeutic Equipment
• 5.3 Monitoring Devices
• 5.4 Surgical Instruments

6 Global Medical & Healthcare Electronics Market, By Product Model

• 6.1 Portable Devices
• 6.2 Stationary Devices
• 6.3 Integrated Systems

7 Global Medical & Healthcare Electronics Market, By Technology

• 7.1 Wearable Technology
• 7.2 Telemedicine Platforms
• 7.3 Health Information Technology (HIT)
• 7.4 Telemonitoring Systems
• 7.5 IoT & Connected Devices
• 7.6 AI & Machine Learning Applications

8 Global Medical & Healthcare Electronics Market, By Application

• 8.1 Functional Applications
  • 8.1.1 Diagnostics
  • 8.1.2 Monitoring
  • 8.1.3 Therapeutics
• 8.2 Clinical Domains
  • 8.2.1 Cardiology
  • 8.2.2 Neurology
  • 8.2.3 Orthopedics
  • 8.2.4 Oncology
  • 8.2.5 Diabetes Management
  • 8.2.6 Respiratory Care

9 Global Medical & Healthcare Electronics Market, By End User

• 9.1 Hospitals & Clinics
• 9.2 Ambulatory Surgical Centers (ASCs)
• 9.3 Home Healthcare
• 9.4 Diagnostic Laboratories
• 9.5 Research Institutes

10 Global Medical & Healthcare Electronics Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Analog Devices, Inc.
• 13.2 TE Connectivity
• 13.3 Texas Instruments Incorporated
• 13.4 STMicroelectronics
• 13.5 NXP Semiconductors
• 13.6 Infineon Technologies AG
• 13.7 GE HealthCare
• 13.8 Microchip Technology Inc.
• 13.9 Siemens Healthineers AG
• 13.10 Koninklijke Philips N.V.
• 13.11 Medtronic plc
• 13.12 Abbott Laboratories
• 13.13 Boston Scientific Corporation
• 13.14 Canon Medical Systems Corporation
• 13.15 Fujifilm Holdings Corporation
• 13.16 Becton, Dickinson and Company
• 13.17 Dragerwerk AG & Co. KGaA
• 13.18 Stryker